Published in Cancer Weekly, April 3rd, 1995
Douglas Antelman et al., of Canji Inc., remark that the tumor suppressor gene, RB, has been the subject of intensive study as it seems to play a central role in regulating normal cellular growth. Biological consequences of RB inactivation include alterations in cellular differentiation, uncontrolled cell proliferation and the genesis of several types of tumors.
Antelman et al. report "Since many cancers are characterized by RB mutation, restoring wild-type RB function to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.